Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Antineoplastic Agents
/ pharmacology
Apoptosis
Biomarkers, Tumor
/ blood
Cell Proliferation
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Neoadjuvant Therapy
/ methods
Prognosis
RNA, Untranslated
/ blood
Triple Negative Breast Neoplasms
/ blood
Tumor Cells, Cultured
Journal
International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
18
04
2019
accepted:
26
09
2019
pubmed:
4
12
2019
medline:
24
10
2020
entrez:
3
12
2019
Statut:
ppublish
Résumé
Due to the positive association between neoadjuvant chemotherapy (NACT) and the promising early response rates of patients with triple negative breast cancer (TNBC), including probabilities of pathological complete response, NACT is increasingly used in TNBC management. Liquid biopsy‑based biomarkers with the power to diagnose the early response to NACT may support established monitoring tools, which are to a certain extent imprecise and costly. Simple serum‑ or urine‑based analyses of non‑coding RNA (ncRNA) expression may allow for fast, minimally‑invasive testing and timely adjustment of the therapy regimen. The present study investigated breast cancer‑related ncRNAs [microRNA (miR)‑7, ‑9, ‑15a, ‑17, ‑18a, ‑19b, ‑21, ‑30b, ‑222 and ‑320c, PIWI‑interacting RNA‑36743 and GlyCCC2] in triple positive BT‑474 cells and three TNBC cell lines (BT‑20, HS‑578T and MDA‑MB‑231) treated with various chemotherapeutic agents using reverse transcription‑quantitative PCR. Intracellular and secreted microvesicular ncRNA expression levels were analysed using a multivariable statistical regression analysis. Chemotherapy‑driven effects were investigated by analysing cell cycle determinants at the mRNA and protein levels. Serum and urine specimens from 8 patients with TNBC were compared with 10 healthy females using two‑sample t‑tests. Samples from the patients with TNBC were compared at two time points. Chemotherapeutic treatments induced distinct changes in ncRNA expression in TNBC cell lines and the BT‑474 cell line in intra‑ and extracellular compartments. Serum and urine‑based ncRNA expression analysis was able to discriminate between patients with TNBC and controls. Time point comparisons in the urine samples of patients with TNBC revealed a general rise in the level of ncRNA. Serum data suggested a potential association between piR‑36743, miR‑17, ‑19b and ‑30b expression levels and an NACT‑driven complete clinical response. The present study highlighted the potential of ncRNAs as liquid biopsy‑based biomarkers in TNBC chemotherapy treatment. The ncRNAs tested in the present study have been previously investigated for their involvement in BC or TNBC chemotherapy responses; however, these previous studies were restricted to patient tissue or in vitro models. The data from the present study offer novel insight into ncRNA expression in liquid samples from patients with TNBC, and the study serves as an initial step in the evaluation of ncRNAs as diagnostic biomarkers in the monitoring of TNBC therapy.
Identifiants
pubmed: 31789396
doi: 10.3892/ijo.2019.4920
pmc: PMC6910196
doi:
Substances chimiques
Antineoplastic Agents
0
Biomarkers, Tumor
0
RNA, Untranslated
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-68Références
Cell Physiol Biochem. 2016;38(6):2152-62
pubmed: 27185036
Transl Res. 2018 Oct;200:1-17
pubmed: 30053382
Medicine (Baltimore). 2016 Aug;95(35):e4614
pubmed: 27583878
Mol Endocrinol. 2011 Feb;25(2):199-211
pubmed: 20861225
Sci Rep. 2017 Jan 25;7:41309
pubmed: 28120942
Int J Cancer. 2008 Jul 1;123(1):236-40
pubmed: 18398844
Mol Cell Proteomics. 2012 Feb;11(2):M111.011932
pubmed: 22086602
Cell Death Differ. 2013 Dec;20(12):1603-14
pubmed: 24212931
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Sci Rep. 2016 Aug 24;6:31992
pubmed: 27553688
Cancer Res. 2016 Sep 15;76(18):5562-72
pubmed: 27402080
Anticancer Drugs. 2018 Jul;29(6):539-548
pubmed: 29557813
BMC Cancer. 2009 Oct 10;9:359
pubmed: 19818145
Breast Cancer Res Treat. 2014 Feb;144(1):153-62
pubmed: 24504379
Cancer Gene Ther. 2014 Jul;21(7):290-6
pubmed: 24924200
J Surg Res. 2019 Jan;233:426-435
pubmed: 30502282
Gynecol Oncol. 2015 Apr;137(1):143-51
pubmed: 25579119
Br J Cancer. 2017 Jun 27;117(1):89-101
pubmed: 28571043
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5768-72
pubmed: 10811891
Mol Cancer. 2017 Jul 25;16(1):132
pubmed: 28743280
BMC Biol. 2016 Jun 13;14:46
pubmed: 27296830
Arch Biochem Biophys. 2018 May 1;645:54-60
pubmed: 29550144
J Exp Clin Cancer Res. 2018 Oct 20;37(1):257
pubmed: 30342533
J Cell Physiol. 2019 Jul;234(7):11768-11779
pubmed: 30488443
Clin Chem. 2015 Nov;61(11):1333-42
pubmed: 26408530
Pathol Res Pract. 2017 Oct;213(10):1264-1270
pubmed: 28935174
Oncotarget. 2017 Feb 28;8(9):15763-15774
pubmed: 28178652
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652):
pubmed: 25135963
Ann Surg. 2006 Feb;243(2):257-64
pubmed: 16432360
Breast Cancer Res. 2014 Jul 28;16(4):R78
pubmed: 25069832
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
Cancer Sci. 2018 Sep;109(9):2897-2906
pubmed: 29981251
BMC Bioinformatics. 2014 Jan 28;15:29
pubmed: 24472427
BMC Cancer. 2015 Jul 08;15:509
pubmed: 26152689
EMBO J. 2005 Feb 9;24(3):543-53
pubmed: 15660129
Onco Targets Ther. 2018 Jul 16;11:4087-4095
pubmed: 30038508
Tumour Biol. 2017 Jul;39(7):1010428317707372
pubmed: 28714373
Genome Biol. 2009;10(6):R64
pubmed: 19531210
Oncotarget. 2018 Jan 9;9(10):9030-9042
pubmed: 29507672
Breast Cancer Res. 2018 Jul 11;20(1):72
pubmed: 29996899
Biochim Biophys Acta Gene Regul Mech. 2018 Nov;1861(11):996-1006
pubmed: 30343695
J Cancer. 2018 Jan 1;9(1):135-140
pubmed: 29290778
Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2526-31
pubmed: 27383301
Br J Surg. 2007 Oct;94(10):1189-200
pubmed: 17701939
Tumour Biol. 2017 Jun;39(6):1010428317702899
pubmed: 28621239
Arch Biochem Biophys. 2019 Jan;661:22-30
pubmed: 30389444
Cell Death Dis. 2016 Nov 10;7(11):e2463
pubmed: 27831559
RNA Biol. 2013 Jan;10(1):121-32
pubmed: 23353573
Med Oncol. 2014 Jul;31(7):57
pubmed: 24930006
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Methods Mol Biol. 2012;822:261-72
pubmed: 22144205
Gynecol Oncol. 2014 Mar;132(3):739-44
pubmed: 24472409
J Clin Oncol. 2001 Nov 15;19(22):4224-37
pubmed: 11709566
Biosci Rep. 2018 Sep 20;38(5):
pubmed: 30126852
Clin Transl Oncol. 2018 Jul;20(7):906-911
pubmed: 29143228
Neoplasma. 2019 Jan 15;66(1):54-62
pubmed: 30509089
Med Sci Monit. 2018 Apr 23;24:2476-2488
pubmed: 29683112
J Clin Oncol. 2012 May 20;30(15):1796-804
pubmed: 22508812
J Clin Oncol. 2013 Oct 10;31(29):3623-30
pubmed: 24002511
J Cell Mol Med. 2015 Dec;19(12):2874-87
pubmed: 26416600
Oncotarget. 2016 Nov 1;7(44):71235-71254
pubmed: 27659519
Jpn J Clin Oncol. 2000 Dec;30(12):562-7
pubmed: 11210167
J Cell Biochem. 2018 Nov 28;:
pubmed: 30485486
ACS Appl Mater Interfaces. 2018 Aug 15;10(32):26954-26963
pubmed: 30028120
ACS Nano. 2018 Nov 27;12(11):10817-10832
pubmed: 30346694
Genes Dev. 1997 Apr 15;11(8):957-72
pubmed: 9136925
Cancer Res. 2018 Sep 15;78(18):5259-5273
pubmed: 30042152
J Exp Clin Cancer Res. 2017 Sep 22;36(1):131
pubmed: 28938919
Oncotarget. 2017 Jul 17;8(38):64330-64343
pubmed: 28969074
Oncotarget. 2018 Feb 13;9(17):13848-13858
pubmed: 29568399
Cell Physiol Biochem. 2017;43(2):840-851
pubmed: 28954272
PLoS One. 2015 Jul 28;10(7):e0133643
pubmed: 26218285
Medicine (Baltimore). 2018 Aug;97(35):e12007
pubmed: 30170406
Breast Cancer. 2018 Mar;25(2):198-205
pubmed: 29101635
J Gastroenterol. 2012 Aug;47(8):883-95
pubmed: 22382630
Molecules. 2014 May 30;19(6):7122-37
pubmed: 24886939
Gene. 2017 Jul 1;619:10-20
pubmed: 28359916
Oncogenesis. 2013 Oct 07;2:e75
pubmed: 24100610
Int J Cancer. 2015 Jun 1;136(11):2730-7
pubmed: 25387885
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
J Breast Cancer. 2017 Mar;20(1):35-44
pubmed: 28382093
Breast Cancer Res Treat. 2017 Apr;162(3):511-521
pubmed: 28181130
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Breast Cancer Res. 2010;12(5):R68
pubmed: 20813035
Ann Transl Med. 2015 Dec;3(21):332
pubmed: 26734642
Sci Rep. 2018 Dec 19;8(1):17981
pubmed: 30568292
Exp Cell Res. 2018 Aug 1;369(1):129-138
pubmed: 29778754
Oncotarget. 2015 Feb 10;6(4):2451-65
pubmed: 25669981
Mod Pathol. 2011 Feb;24(2):157-67
pubmed: 21076464
OMICS. 2018 Nov;22(11):709-716
pubmed: 30388053
Oncotarget. 2014 Oct 30;5(20):9901-10
pubmed: 25313140
J Cell Mol Med. 2019 Jan;23(1):656-669
pubmed: 30338929
Tumour Biol. 2016 Nov;37(11):15315-15324
pubmed: 27699665
Adv Exp Med Biol. 2016;937:207-28
pubmed: 27573902
J Clin Oncol. 1998 Aug;16(8):2672-85
pubmed: 9704717
Gynecol Oncol. 2011 Aug;122(2):366-71
pubmed: 21571355
Cancer Biomark. 2018;22(4):721-726
pubmed: 29914008
J Breast Cancer. 2018 Dec;21(4):363-370
pubmed: 30607157
Mol Cancer. 2016 May 17;15(1):39
pubmed: 27189224
Oncol Lett. 2018 Mar;15(3):3017-3023
pubmed: 29435032
Oncogene. 2011 Mar 3;30(9):1082-97
pubmed: 21057537
Asian Pac J Cancer Prev. 2016;17(4):1887-90
pubmed: 27221871
Sci Rep. 2017 Jan 24;7:41127
pubmed: 28117343
Am J Cancer Res. 2016 Jul 01;6(7):1511-23
pubmed: 27508093
EBioMedicine. 2016 Sep;11:199-209
pubmed: 27566954
Nanomedicine (Lond). 2018 Nov;13(21):2729-2758
pubmed: 30394201
PLoS One. 2013;8(1):e53436
pubmed: 23335963
Ann Oncol. 2005 Jan;16(1):56-63
pubmed: 15598939
Gene. 2016 Dec 31;595(2):221-226
pubmed: 27746365
J Cell Physiol. 2018 Feb;233(2):774-786
pubmed: 28109133
J Breast Cancer. 2018 Jun;21(2):142-149
pubmed: 29963109
PLoS One. 2016 Jan 19;11(1):e0147249
pubmed: 26785265
Mol Med Rep. 2017 May;15(5):2713-2719
pubmed: 28447761
Gene. 2019 Mar 1;687:272-279
pubmed: 30468908
BMC Cancer. 2015 Mar 28;15:193
pubmed: 25886191
Nat Commun. 2018 Apr 24;9(1):1614
pubmed: 29691399
Cancer Res. 2007 Aug 15;67(16):7572-8
pubmed: 17699760
Nat Rev Cancer. 2018 Jan;18(1):5-18
pubmed: 29170536
Int J Biochem Cell Biol. 2017 Sep;90:48-58
pubmed: 28751193
Oncotarget. 2015 Nov 10;6(35):38270-82
pubmed: 26516702
Genome Biol. 2013 Nov 20;14(11):R126
pubmed: 24257477
Biomed Pharmacother. 2014 Oct;68(8):935-42
pubmed: 25451164
Cancer J. 2012 May-Jun;18(3):262-7
pubmed: 22647363
Oncotarget. 2015 Dec 29;6(42):44538-50
pubmed: 26517090
BMC Cancer. 2017 Nov 10;17(1):745
pubmed: 29126392
Anticancer Res. 2017 Dec;37(12):6575-6581
pubmed: 29187432
Radiat Oncol. 2012 Nov 20;7:195
pubmed: 23167930
Mol Med Rep. 2015 Sep;12(3):4692-4702
pubmed: 26130254
Sci Rep. 2017 Sep 4;7(1):10352
pubmed: 28871171
Mol Oncol. 2014 Jul;8(5):874-83
pubmed: 24694649
Oncotarget. 2015 Oct 13;6(31):31944-57
pubmed: 26397135
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005002
pubmed: 17443564
Breast Cancer Res Treat. 2018 Jul;170(2):257-270
pubmed: 29557526
Chin Med J (Engl). 2013 Dec;126(23):4435-9
pubmed: 24286402
Oncotarget. 2017 Aug 24;8(44):77369-77384
pubmed: 29100393
Brief Bioinform. 2016 Mar;17(2):204-12
pubmed: 26238539
Mol Carcinog. 2019 Apr;58(4):554-564
pubmed: 30520151
Br J Cancer. 2013 Jul 23;109(2):502-11
pubmed: 23799850
PLoS One. 2016 Apr 11;11(4):e0152032
pubmed: 27064979
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2194-200
pubmed: 27338042
Artif Cells Nanomed Biotechnol. 2018 May;46(3):518-523
pubmed: 28509576
Biosci Rep. 2019 Jan 15;39(1):
pubmed: 30538172
Int J Oncol. 2019 Jan;54(1):339-347
pubmed: 30387831
J Clin Oncol. 2014 Dec 1;32(34):3883-91
pubmed: 25349292
Sci Rep. 2018 Aug 21;8(1):12522
pubmed: 30131543
PLoS One. 2009 Jul 03;4(7):e6146
pubmed: 19582160
Int J Oncol. 2019 Jan;54(1):239-248
pubmed: 30365113
Technol Cancer Res Treat. 2010 Feb;9(1):77-86
pubmed: 20082533
Colloids Surf B Biointerfaces. 2019 Mar 1;175:231-238
pubmed: 30537619
Cancer Res. 2011 Jul 1;71(13):4443-53
pubmed: 21586611
Gut. 2015 Dec;64(12):1936-48
pubmed: 25887381
Clin Breast Cancer. 2009 Jun;9 Suppl 2:S73-81
pubmed: 19596646
Cell Biochem Biophys. 2015 May;72(1):275-82
pubmed: 27040946
Clin Lab. 2018 Apr 1;64(4):491-496
pubmed: 29739090
PLoS One. 2018 Feb 2;13(2):e0190245
pubmed: 29394261
Nat Cell Biol. 2010 Mar;12(3):247-56
pubmed: 20173740
Dig Dis Sci. 2012 Dec;57(12):3160-7
pubmed: 23001407
Oncotarget. 2016 Aug 23;7(34):55231-55248
pubmed: 27409424
Clinics (Sao Paulo). 2018 Jul 10;73:e184
pubmed: 29995098
Mol Med Rep. 2014 Aug;10(2):785-91
pubmed: 24866395
Artif Cells Nanomed Biotechnol. 2017 Sep;45(6):1-6
pubmed: 27684463
Sci Rep. 2018 Aug 28;8(1):12974
pubmed: 30154547
Cell Discov. 2017 Sep 12;3:17029
pubmed: 28904816
Cell Biol Int. 2017 Dec;41(12):1345-1355
pubmed: 28816390
PLoS One. 2014 Apr 22;9(4):e95716
pubmed: 24755562
Biotechnol Lett. 2004 Mar;26(6):509-15
pubmed: 15127793
Oncotarget. 2017 Aug 24;8(51):88645-88657
pubmed: 29179464
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13021-6
pubmed: 18755890
Arch Biochem Biophys. 2017 Jun 1;623-624:20-30
pubmed: 28495512
J Natl Cancer Inst Monogr. 2015 May;2015(51):90-6
pubmed: 26063896
Arch Med Res. 2011 Jan;42(1):8-14
pubmed: 21376256
Cancer Discov. 2012 Sep;2(9):812-25
pubmed: 22750847
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S555-63
pubmed: 24723223
Leukemia. 2015 Oct;29(10):2015-23
pubmed: 25971364
Int J Oncol. 2015;46(6):2526-34
pubmed: 25846193
PLoS One. 2018 Nov 2;13(11):e0206542
pubmed: 30388154
Hum Pathol. 2017 Oct;68:69-78
pubmed: 28882698
Cancer Res. 2016 Oct 1;76(19):5832-5844
pubmed: 27569215
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Cancer Biomark. 2016;16(3):395-403
pubmed: 27062696
Int J Clin Exp Med. 2015 Aug 15;8(8):13353-8
pubmed: 26550265
Cell Physiol Biochem. 2017;44(2):804-816
pubmed: 29176322
Tumour Biol. 2014 Aug;35(8):7733-41
pubmed: 24810926
Int J Biochem Cell Biol. 2018 Sep;102:59-70
pubmed: 29953965
Biochem Biophys Res Commun. 2018 Feb 19;496(4):1308-1313
pubmed: 29408336
Cancer Prev Res (Phila). 2017 Jan;10(1):89-97
pubmed: 27789587
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Oncotarget. 2017 Sep 11;8(48):83940-83948
pubmed: 29137394
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62
pubmed: 24114568
Histopathology. 1991 Nov;19(5):403-10
pubmed: 1757079
Oncotarget. 2017 Nov 8;8(66):110671-110684
pubmed: 29299178
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Adv Exp Med Biol. 2016;937:3-17
pubmed: 27573892
Am J Cancer Res. 2016 Jul 01;6(7):1461-93
pubmed: 27508091
Pharmacogenomics J. 2019 Feb;19(1):5-14
pubmed: 30190521
Nucleic Acids Res. 2007;35(11):3590-601
pubmed: 17485482
Med Oncol. 2017 Jan;34(1):2
pubmed: 27889881
PLoS One. 2018 Jan 11;13(1):e0191195
pubmed: 29324832
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
APMIS. 2018 Apr;126(4):303-308
pubmed: 29575198
Cell Mol Biol (Noisy-le-grand). 2016 Nov 30;62(13):29-34
pubmed: 28040059
Biomarkers. 2018 Dec;23(8):804-811
pubmed: 30010434
Oncogene. 2009 Nov 19;28(46):4053-64
pubmed: 19718048
Oncol Rep. 2018 Mar;39(3):1003-1010
pubmed: 29328395
Biotechnol Bioeng. 2018 Oct;115(10):2613-2623
pubmed: 29981261
Gynecol Oncol. 2013 Sep;130(3):588-94
pubmed: 23811003
Nat Commun. 2018 Nov 9;9(1):4718
pubmed: 30413718
Apoptosis. 2008 Oct;13(10):1215-22
pubmed: 18758960
Contemp Oncol (Pozn). 2015;19(6):423-7
pubmed: 26843836
Gynecol Oncol. 2008 Dec;111(3):478-86
pubmed: 18823650
Anal Chim Acta. 2018 Dec 26;1042:109-115
pubmed: 30428976
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2201-8
pubmed: 27338043
Oncogene. 2018 Oct;37(43):5794-5809
pubmed: 29973690
Microvasc Res. 2018 Nov;120:21-28
pubmed: 29777792
Cell Physiol Biochem. 2018;48(5):2205-2218
pubmed: 30110679
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
J Ovarian Res. 2017 Apr 4;10(1):24
pubmed: 28376831
Epigenomics. 2017 Sep;9(9):1175-1188
pubmed: 28803498
PLoS One. 2015 Nov 25;10(11):e0143755
pubmed: 26606261
Tumour Biol. 2016 Jun;37(6):7245-54
pubmed: 26666820
J Med Chem. 2018 Jul 26;61(14):5900-5909
pubmed: 29993250
Neoplasma. 2019 Mar 5;66(2):232-239
pubmed: 30509108
Am J Transl Res. 2017 Mar 15;9(3):953-961
pubmed: 28386324
Life Sci. 2016 Nov 1;164:60-70
pubmed: 27596816
Oncotarget. 2016 Jun 14;7(24):35789-35802
pubmed: 27119506
Anticancer Res. 2015 Jan;35(1):123-7
pubmed: 25550542
Clin Cancer Res. 2014 Mar 1;20(5):1298-305
pubmed: 24520097
J Biol Res (Thessalon). 2015 Oct 22;22:12
pubmed: 26500892
Breast Cancer Res Treat. 2011 Jan;125(1):145-56
pubmed: 21042932
Oncol Rep. 2017 Jun;37(6):3297-3304
pubmed: 28440475
J Cell Biochem. 2019 Apr;120(4):5666-5676
pubmed: 30335891
J Virol. 2003 Jan;77(1):1-9
pubmed: 12477805
Sci Rep. 2018 Jun 25;8(1):9657
pubmed: 29941867
Oncol Lett. 2017 Dec;14(6):6929-6936
pubmed: 29151919
Curr Opin Cell Biol. 2009 Jun;21(3):416-25
pubmed: 19447594
Am J Transl Res. 2017 Feb 15;9(2):683-691
pubmed: 28337296
Hum Pathol. 2017 Jun;64:44-52
pubmed: 28412211
Cell Death Differ. 2019 May;26(5):843-859
pubmed: 29988076
Gene. 2017 Jan 5;596:110-118
pubmed: 27746366
Ann Surg Treat Res. 2017 Feb;92(2):55-66
pubmed: 28203552
Oncotarget. 2017 Jul 22;8(41):69934-69944
pubmed: 29050253
Cancer Med. 2018 Sep;7(9):4420-4433
pubmed: 30099860
Oncotarget. 2016 Sep 27;7(39):64100-64108
pubmed: 27602768
Mol Pharm. 2018 Sep 4;15(9):3767-3776
pubmed: 29966415
Cell Biosci. 2018 Mar 22;8:23
pubmed: 29588850
Anal Biochem. 1987 Nov 1;166(2):368-79
pubmed: 2449095
J Clin Oncol. 2008 Feb 10;26(5):778-85
pubmed: 18258986
Br J Cancer. 2015 May 26;112(11):1751-9
pubmed: 25906045
Breast Cancer Res. 2016 Sep 08;18(1):90
pubmed: 27608715
Clin Transl Oncol. 2017 Sep;19(9):1133-1140
pubmed: 28397066
J Clin Oncol. 2008 Mar 10;26(8):1275-81
pubmed: 18250347
Int J Breast Cancer. 2017;2017:1796145
pubmed: 28912973
Oral Oncol. 2011 Mar;47(3):202-10
pubmed: 21292542
PLoS One. 2012;7(7):e40008
pubmed: 22808086
Asian Pac J Cancer Prev. 2016;17(4):1801-10
pubmed: 27221856
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
PLoS One. 2016 Jul 12;11(7):e0158946
pubmed: 27404381
Cancer Lett. 2016 Oct 1;380(2):434-41
pubmed: 27400681
Breast Cancer Res. 2013 May 24;15(3):R42
pubmed: 23705859
Onco Targets Ther. 2017 Jan 27;10:543-550
pubmed: 28203087
World J Gastroenterol. 2014 Oct 28;20(40):14904-12
pubmed: 25356050